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ABSTRACT
In 2018, Bhutan reported 54 cases of malaria, of which six were indigenous, 14 introduced 
and 34 imported. Considering the continuous reduction in the number of indigenous cases, 
Bhutan plans to eliminate malaria by 2025 under the Bhutan Malaria Elimination Strategy. 
The study was conducted to assess the presence of asymptomatic plasmodial infection in 
both, Bhutanese population living in malaria-risk areas and in migrant workers to guide the 
elimination strategies. A cross-sectional study was conducted from April to May 2016 in 
750 Bhutanese people and 473 migrant workers. Plasmodium falciparum and Plasmodium 
vivax infections were investigated by using a rapid diagnostic test (RDT) and the polymerase 
chain reaction (PCR). Prevalence of asymptomatic plasmodial infection based on PCR was 
0.27% (95% CI: 0.05–1.07%) among Bhutanese people with a mean age of 43 years old. 
The proportions of males and females were 45% and 55%, respectively. Among migrant 
workers, the prevalence of asymptomatic plasmodial infection was 0.42% (95% CI: 0.07–
1.69%) with a mean age of 30 years old. The majority of migrant workers were from the 
neighboring Indian State of West Bengal (57.51%), followed by Assam (12.26%). RDT in 
both study groups did not detect any plasmodial infection. The presence of a low prevalence 
of asymptomatic plasmodial infection indicates that the current elimination strategies and 
interventions are effective. 
KEYWORDS: Malaria. Asymptomatic. Malaria elimination. Bhutan. PCR. Rapid Diagnostic 
Test (RDT).
INTRODUCTION
Globally, the incidence rate of malaria has decreased from 72 to 59 cases per 
1,000 at risk inhabitants between 2010 and 2017, a 18% reduction1. An estimated 
219 million cases of malaria occurred worldwide in 2017 compared to 239 million 
cases in 2010. However, the estimates for 2015-2017 were almost similar, suggesting 
no progress in reducing the malaria burden during these last three years. In 2017, 
malaria resulted in an estimated 435,000 deaths globally compared to 607,000 
deaths in 2010, with a 28% decrease in mortality1. This reduction was attributed to 
the availability of highly effective antimalarial drugs and long-lasting insecticide 
nets (LLINs), as well as a mutual investment to provide treatment and preventive 
measures to the people in need1-3. Most malaria cases were reported from the 
African World Health Organization (WHO) (92%), followed by the South-East Asia 
Region WHO (5%), and the Eastern Mediterranean Region WHO (2%). Notably, 
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the highest numbers of malaria cases and deaths (93%) were 
reported from the African WHO, mostly in children under 
five years of age1. To accelerate progress in reducing the 
burden of malaria, WHO endorsed the Global Technical 
Strategy for Malaria 2016–2030 (GTS) which set a vision 
to eliminate malaria in 35 countries by 2030 and in at least 
ten countries by 2020 1.
Bhutan has achieved a significant reduction of malaria 
incidence from 1,868 indigenous cases in 2006 to only six 
indigenous cases in 20184-8. The geographical distribution 
of malaria infection has also decreased from 15 of the 
20 districts in 2006 to only two districts in 20184,6. The 
dramatic decline in malaria cases is believed to be due to the 
high coverage of LLINs, intensified surveillance and early 
diagnosis and treatment5,6,9,10. Bhutan plans to eliminate 
malaria by 20259. However, imported and reintroduced 
cases along the international border with some Indian 
States remain a significant concern as seven of the seven 
Bhutanese districts (Chukha, Dagana, Pemagatshel, Samtse, 
Samdrup Jongkhar, Sarpang, and Zhemgang) share porous 
international borders with Assam, West Bengal, Arunachal 
Pradesh and Sikkim, in India. Among these States, Assam 
and West Bengal borders have intense cross-border activity, 
and most cases are reported in areas bordering Assam5,11,12. 
Percentages of imported malaria cases have increased from 
79.7% of the total malaria cases detected in Bhutan in 2016 
to 82.33% in 2017, and 88.9% in 20184,10,13.
In Bhutan, Plasmodium species that cause malaria are 
P. falciparum and P. vivax. Anopheles species recorded 
and considered as malaria vectors in Bhutan are An. 
minimus, An. fluviatilis, An. dirus, An. pseudowillmori 
and An. culicifacies13. However, no studies on vectors 
including their ecology and behaviors have been conducted 
in Bhutan. The primary malaria control intervention 
adopted in the country includes mandatory screening for 
plasmodial infections in any fever case, early detection and 
treatment, active case finding to detect foci of transmission, 
community awareness and education. In addition, vector 
control by the universal coverage of LLINs, indoor residual 
spraying (IRS), clearing bushes and avoiding stagnation 
of water in the surrounding have also been implemented. 
While malaria incidence has dramatically declined, there 
is not much information on asymptomatic reservoirs in 
the country. Some evidences suggest that a significant 
proportion of asymptomatic reservoirs are present in both, 
high and low transmission settings14,15. The diagnosis of 
asymptomatic plasmodial infections in people living in low 
transmission settings cannot be made by commonly used 
diagnostic methods, i.e., microscopic examination and rapid 
diagnostic tests (RDT)16. To achieve malaria elimination, 
it is essential to ascertain the burden of asymptomatic 
reservoirs in the population at risk, as well as in migrant 
workers from malaria-endemic countries, particularly 
India14,17, and proactively detect and treat asymptomatic 
plasmodial infections with effective antimalarial drugs18-21.
This study aimed to estimate the prevalence of 
asymptomatic plasmodial infections in the population living 
in at risk malaria areas in Bhutan, as well as in migrant 
workers from India. This information is essential to support 
the implementation of malaria elimination strategies in 
pursuit of elimination by 20259.
MATERIALS AND METHODS
Study area and sample size
A cross-sectional survey was conducted to determine 
the prevalence of asymptomatic P. vivax and P. falciparum 
infections targeting populations living in risk areas for 
malaria in seven districts of Bhutan, i.e., Chukha, Dagana, 
Pemagatshel, Samtse, Sarpang Samdrup Jongkhar, and 
Zhemgang (Figure 1). The study period coincided with 
the peak of the malaria season in April to May 2016. 
Based on the records maintained by 16 health centers 
in the risk areas they consisted of 6,319 households and 
28,583 people, accounting for approximately 4% of the 
country’s population. For the estimation of the prevalence 
of asymptomatic plasmodial infections (P. vivax and 
P. falciparum), catchment areas of two health centers in 
each of these districts located in malaria risk areas (based 
on the number of cases detected from 2011-2015) were 
intentionally selected22. From each selected health center, 
approximately four villages (primary sampling units) 
were randomly selected and from each selected village, 
a maximum of ten households (secondary sampling 
units) were selected using a systematic random sampling 
technique (based on data maintained by VDCP and health 
centers). When the selected village had less than ten 
households, additional village(s) were randomly sampled, 
from the eligible list of villages in the catchment area 
of the selected health centers. From each household, a 
single member in the eligible list of household members 
was randomly sampled based on the inclusion criteria: 
(i) individual residing in a household that received LLINs 
distributed by the Vector-Borne Disease Control program 
in 2014; (ii) had not been diagnosed or treated for malaria 
during the last 21 days (based on the maximum incubation 
period23), (iii) aged ≥18 years on the date of the survey, 
(iv) resident in the locality for ≥ 1 years and (v) agreed to 
participate in the study. 
Using a 95% confidence interval (95% CI), an error 
of 2% and an anticipated asymptomatic prevalence of 5% 
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(the expected prevalence of 5% was assumed although 
previous small-scale studies reported a prevalence of 
asymptomatic plasmodial infections < 1%5). The required 
sample size was 457 participants. To account for the loss 
and missing information (approximately 10%), the sample 
size was rounded to 500. Taking the maximum design effect 
of 1.518, 750 individuals were included in the analysis 
using the formula N= (Zα/2)2*P (1-P)*DEFF/ ME2, where 
N is the sample size, Zα/2 is the critical α level, P is the 
anticipated asymptomatic malaria prevalence, DEFF is the 
design effect, and ME is the marginal error.
Migrant workers were enrolled in three main entry 
points, i.e., Phuntsholing, Gelephu and Samdrup Jongkhar. 
All migrant workers underwent compulsory medical 
examination for entry into Bhutan. To this end, there were 
five registered private diagnostic centers in Phuntsholing, 
two in Gelephu and one in Samdrup Jongkhar. The sample 
size required for the estimation of the prevalence of 
asymptomatic malaria in this group of migrant workers was 
estimated using the same formula (without adjusting for the 
design effect DEFF assuming a within-private-diagnostic-
centers variance of zero). Therefore, the estimated sample 
size for migrant workers entering Bhutan through these 
entry points was 500 individuals. Since over 50% of the 
workers entered through Phuntsholing, and around 50% 
through Gelephu and Samdrup Jongkhar, 250 individuals 
were randomly sampled in Phuntsholing and 125 individuals 
in Gelephu and the same number in Samdrup Jongkhar.
Approval of the study protocol was obtained from the 
Research Ethics Board of Health (REBH), Ministry of 
Health, Royal Government of Bhutan (approval No. REBH/
Approval/2016/016). Written informed consent was 
obtained from the head of each household (HH) family. The 
interviewers explained the purpose, the risks and benefits 
of the study in the participant language and participation 
in the survey were voluntary. Written information on the 
survey was translated into Dzongkha for Bhutanese and 
Hindi for migrant workers and provided to all participants. 
Participants’ demographics were collected using a 
structured questionnaire.
Sample collection and testing
Venous blood samples were collected from all the subjects 
for the RDT and three aliquots of 50 μL were directly spotted 
onto filter papers (Whatman No. 3 MM, GE Healthcare 
UK Limited, Buckinghamshire, United Kingdom). Venous 
blood sample collection was chosen due to the difficulty to 
obtain adequate blood samples volumes by the finger-prick 
procedure as most farmers in the community had hard finger 
skins due to the type of work they do. Each filter paper (Dried 
Blood Spot, DBS) was air-dried at 25 oC overnight, kept in 
Figure 1 - Bhutan’s chiwog map (small administrative units are in dotted lines) and the district map (bold lines) shows the sampling 
sites (shaded in black color) to estimate the prevalence of asymptomatic malaria in the community and in migrant workers at the 
three border entry points (triangles).
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a zip-lock plastic bag containing desiccants and stored at 
25 o C until it was sent to the laboratory and processed24,25.
The RDT used in the study was the FirstSignTM – 
ParaView-2 (Unimed, Volmolenheide, Belgium) and the test 
was performed according to the manufacturer’s instructions. 
This immuno-chromatography test detects P. falciparum 
specific histidine-rich protein-2 (HRP-2) and P. vivax 
specific pLDH.
Genomic DNA was extracted from DBS samples using 
the QIAamp DNA Mini Kit (QIAGEN®, Hilden, Germany) 
according to the manufacturer’s instructions. The extracted 
DNA was stored at -20 °C until use. Nested PCR assay was 
carried out as previously described26. DNA samples were 
amplified using species-specific primer pairs designed to 
amplify small subunit ribosomal ribonucleic acid (ssrRNA) 
genes of P. falciparum and P. vivax. The outer primers 
were rPLU 1: 5’TCAAAGATTAAGCCATGCAAGTGA3’ 
and rPLU5: 5’CCTGTTGTTGCCTTAAACTCC3’. The 
primers used for nested PCR for P. falciparum were FA
L1:5’TTAAACTGGTTTGGGAAAACCAAATATATT3’ 
and FAL2: 5’ACACAATGAACTCAATCATGACTACCC
GTC3’ and for P. vivax VIV1: 5’CGCTTCTAGCTTAATC
CACATAACTGATAC3’ and VIV2:5’ACTTCCAAGCCG 
AAGCAAAGAAAGTCCTTA3. In brief, the primary 
amplification was carried out in a total volume of 25 μL 
containing 1X buffer, 3.5 mM MgCl2, 0.2 mM dNTPs, 
0.2 μM primers and 1 U Taq DNA-polymerase, 2.0 μL 
of extracted DNA (25 ng), and nuclease-free water in a 
T100TM Thermal cycler (BioRaid, Singapore). The nested 
amplification was carried out in a 20 μL reaction volume 
containing the same reaction mixture, P. falciparum and 
P. vivax species-specific primer, and 1 μL of the PCR 
product from the primary amplification. Thermal cycling 
conditions for the first round of amplification were as 
follows: initial denaturation at 94 °C for 1 min, followed 
by 35 cycles of 30 s at 94 °C, 60 s for 55 °C and 60 s at 
72 °C, followed by a final extension of 10 min at 72 °C. 
The cycling conditions for the second PCR were similar, 
excepting for the annealing temperature that was set at 
58 °C. Negative and positive controls were included in each 
experiment. Amplicons were separated by 2% agarose gel 
electrophoresis at 100 V with the molecular weight marker 
100 bp DNA ladder (Bioline, Memphis, USA). The presence 
or absence of different Plasmodium species was confirmed 
by the presence of a 205 bp amplicon for P. falciparum and 
a 117 bp amplicon for P. vivax.
Statistical analysis
All data were entered into the Epi Info™ version 7.2.0.1, 
and statistical analysis was performed using the Stata 
version 14.0 (Stata Statistical Software, Release 14: Stata 
Corp, College Station, TX, USA). 
The frequencies of asymptomatic malaria caused by 
the two species are summarized as proportions, with 95% 
confidence intervals (95% CI).
RESULTS
Demographic characteristics of the participants
Participants from malaria risk areas
A total of 750 participants were enrolled from 75 villages 
in malaria risk areas of the seven districts of Bhutan. The 
participants’ age ranged from 18 to 84 years, with a mean 
age of 45 years old. The male to female participants’ ratio 
was 1:1.2. The participants were predominantly farmers 
(91.87%), and the remaining participants were students, 
business people, government/private employees and 
religious practitioners.
Migrant workers
From a total of 500 migrant workers, 473 were enrolled 
in five private diagnostic centers (Druk Diagnostic, 
Garuda Diagnostic Center, New Life Diagnostic Service, 
Phuntsholing Diagnostic Center, and Samdrup Jongkhar 
Diagnostic Center) at the three border entry points 
(Phuntsholing, Gelephu, and Samdrup Jongkhar). All of 
them were males with age ranging from 18 to 66 years 
(mean of 30 years). Most were from West Bengal (57.51%), 
followed by Assam (12.26%) and the remaining were 
from Bihar, Uttar Pradesh, Himachal Pradesh, Manipur 
and Orissa. Information on the States in India where they 
used to live was not obtained from a significant part of the 
migrant workers (27.27%). 
Detection of P. falciparum and P. vivax parasitemia by 
RDT and PCR
Participants from malaria risk areas
From the total of 750 samples collected from villagers, 
11 (1.46%) samples were not tested by RDT as one of the 
clusters had inadequate RDT. All of the 739 samples showed 
negative results by RDT. Based on the PCR analysis, 2 of the 
739 samples were positive (0.27%) for P. vivax and none for 
P. falciparum. The estimated prevalence of asymptomatic 
plasmodial infections in the studied areas was 0.27% (95% 
CI: 0.05-1.07%) (Table 1). Positive samples were obtained 
from Chukha district, one sample from Lingden village 
(32 years old male) and another sample from Kothilina 
villager (a 38 years old male). All positive cases were treated 
according to the national protocol.
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Migrant workers
From the total of 473 migrant worker samples, all of 
them showed negative results by RDT, and only 2 samples 
showed positive results for P. vivax PCR. One P. vivax 
positive infection was from Assam (a 21 years old male), 
and another one was from West Bengal (a 27 years 
old male). The estimated prevalence of asymptomatic 
plasmodial infections in this group of migrant workers was 
0.42% (95% CI: 0.07-1.69%) (Table 1).
DISCUSSION
Asymptomatic and submicroscopic parasitemia 
reservoirs can sustain the continuous transmission of malaria 
even in low transmission settings if they are not accurately 
detected by a highly sensitive detection method and 
immediately treated by an effective antimalarial drug14-16. 
Therefore, it is essential to address the asymptomatic 
and submicroscopic parasitemia in the population to 
achieve malaria elimination16. Most countries with low 
transmission settings and striving to eliminate malaria, 
including Bhutan, have observed a large proportion of 
asymptomatic plasmodial infections, particularly of cases 
with submicroscopic parasitemia3,20,21,27.
This study is the first report on asymptomatic plasmodial 
infections that represented all malaria risk areas in 
Bhutan5. PCR was used in addition to RDT for malaria 
detection. This study was conducted during the pre-
monsoon season (April-May 2016) coinciding with the 
peak of the malaria season in the country, to maximize 
the detection of asymptomatic reservoirs. Results suggest 
that the prevalence of asymptomatic and submicroscopic 
parasitemia cases could be very low (0.27%) in the malaria 
risk areas in Bhutan. The two positive cases detected were 
P. vivax infections. Although this study was conducted 
in 2016, we believe that the prevalence of asymptomatic 
plasmodial infections remains unchanged. The prevention 
and control program in these areas have been maintained 
at the same level. There was no significant political and 
socio-economic changes in the country. The malaria cases 
decreased in 2018 compared to 2016. Nevertheless, Bhutan 
needs to strengthen and sustain an optimal surveillance, 
even though the prevalence of asymptomatic plasmodial 
infections was very low. The following reasons support this 
proposal: (i) Bhutan shares open borders with endemic areas 
of Indian States (Assam and West Bengal), (ii) The climate 
conditions in these border areas include other high-risk 
areas with tropical and subtropical climate and (iii) there 
is abundance of vector mosquito populations in these areas. 
Results indicate that the current elimination strategies and 
interventions have been effective in interrupting malaria 
transmission in populations at risk, and asymptomatic 
and submicroscopic parasitemia cases are an insignificant 
source of malaria transmission in Bhutan. The observation 
is in agreement with previous reports from Sri Lanka28,29, 
Iran30, Soloman Islands31 and Paraguay32. All these 
reports suggest the reduction of cases of asymptomatic 
and submicroscopic parasitemia malaria with decreased 
symptomatic malaria cases in the population at risk. The 
absence of asymptomatic plasmodial infections in Bhutan 
Has been previously reported5, but the study was limited 
to only four risk areas of the two districts bordering the 
Assam State of India (Sarpang and Samdrup Jongkhar). 
Besides, the method used for the detection of asymptomatic 
plasmodial infections was the RDT, which has poor 
sensitivity compared to PCR3,5,19-21.
A low prevalence of asymptomatic plasmodial infections 
was expected in Bhutan due to its low malaria transmission 
sustained over a long period. This could be attributed 
to the country’s relentless effort in ensuring preventive 
measures such as the provision of LLINs and IRS, as 
well as the policy to perform the compulsory screening 
of all fever cases in malaria risk areas for early detection 
and treatment of the disease. Bhutan launched active case 
finding strategies targeting asymptomatic plasmodial 
infections as early as 2012. For the preparation towards 
the malaria elimination, the program included reactive 
case detection methods for the identification of parasite 
transmission foci, and proactive case detection methods in 
the screening of all migrant workers at border districts10,33-36. 
Table 1 - Detection of P. falciparum and P. vivax infections by RDT and PCR in participants from malaria risk areas (750 cases) 
and migrant workers from the three border entry points (473 cases). Data are presented as numbers (percentages) and 95% 
confidence intervals (CI) when  appropriate.
Malaria risk areas ( N = 750) Migrant workers (N = 473)
RDT 
(n = 739)
PCR 
(n = 735)
RDT 
(n =473)
PCR 
(n =473)
P. falciparum 0 (0) 0 (0) 0 (0) 0 (0)
P. vivax 0 (0) 2 (0.27%) 
(95% CI: 0.05-1.07%)
0 (0) 2 (0.42%) 
(95% CI: 0.07 – 1.69%)
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The LLIN’s coverage exceeded 90% since 2006, and 
successive surveys on indicators have also reported very 
high coverages13,34,35. Malaria cases were also dramatically 
reduced from 465 cases in 2010 to 104 cases in 2015, with 
65% of imported cases. Notably, 54% of the imported cases 
were non-national13. Among the indigenous cases, 74% 
were residing close to the Bhutan-India border, suggesting 
an active transmission in pockets of border areas due to the 
continuous movement of people across the border12. The 
genetic analyses have also suggested an active transmission 
in border areas, as the same genotype was found in both, 
Bhutanese and non-national (Indian) people37.
Most of the migrant workers were from Indian States 
of West Bengal (57.51%), followed by Assam (12.26%). 
The remaining cases were from Bihar, Uttar Pradesh, 
Himachal Pradesh, Manipur and Orissa. These figures were 
in agreement with previous reports on the high number of 
imported cases from West Bengal, Assam and Bihar in 
the past years due to its proximity38-40 and the majority of 
migrant workers coming from these two regions. All of 
these States are endemic to malaria and responsible for the 
highest number of malaria cases and deaths in India11,41. 
High prevalences of asymptomatic malaria cases have also 
been reported in a tribal population in Eastern and North 
East India14,41. Contrary to our expectations, despite the high 
incidence of malaria cases in these States, a low prevalence 
of asymptomatic malaria was found in these imported cases 
(0.48%). Mass malaria screening of migrant workers has 
been routinely implemented, annually, by the Vector-Borne 
Disease Control Program (VDCP) in different hydropower 
project sites in which very low prevalences of asymptomatic 
malaria cases were reported in Bhutan. Although a regular 
screening process at the point of entry is mandatory, the 
current RDT may not be sufficient to prevent asymptomatic 
carriers from entering Bhutan indicating the need for more 
regular and strengthened surveillance systems to monitor 
this population.
In 2014, VDCP screened 4,689 migrant workers in 
various hydropower projects sites also including Bhutanese 
people and only three P. vivax cases (0.06%) were detected. 
In 2015, only one P. vivax and one P. falciparum (0.05%) 
cases were detected from 3,754 migrant workers screened 
with no asymptomatic case detected from 1,534 people 
screened in 201639,40. However, the method used for the 
screening at these sites was microscopy and RDTs. Based 
on PCR analysis, absence of asymptomatic malaria cases 
has also been reported in the malaria-endemic area of Assam 
State42. The low prevalence among migrant workers may 
also be attributed to the intensified malaria prevention and 
control activities in India43. The forest and illegal population 
dwelling inhabiting the international border may be greatly 
affected by malaria, but they may not be among the screened 
migrant workers. Only migrant workers moving for longer 
periods in Bhutan, but not daily workers who move on a 
daily basis were screened for malaria. According to the 
annual report of National Vector Borne Disease Control 
Program of India, the number of malaria cases decreased 
from 55,793 in 2012 to 26,240 in 2016 in West Bengal (a 
47% reduction) and from 29,999 in 2012 to 6,948 in 2016 
in Assam (a 23% reduction)44. The endemicity greatly 
varies within areas in these States44. Based on the results 
of this study, the asymptomatic reservoirs may not be 
a significant concern or barrier to the Bhutan’s malaria 
elimination effort. However, a continuous high LLIN’s 
coverage, special attention to the screening of migrant 
workers at border points and periodic mass screening at 
hydropower projects using more sensitive malaria detection 
methods such as RDT and PCR is required to eliminate 
any potential source of infection represented by both 
symptomatic and asymptomatic cases. To achieve Bhutan 
effort of malaria elimination in 2020, the current strategy of 
screening migrant workers at entry points and hydropower 
projects should be continued along with supportive control 
measures. 
Low-density infections are common in asymptomatic 
individuals. Both, microscopy and RDT usually miss 
detection of infections when parasite densities are low 
(<10 parasites/μL). One of the most used RDT, is based 
on the capture of the parasite antigen by monoclonal 
antibodies (P. falciparum specific HRP-2 and P. vivax 
specific pLDH). The test is very convenient, but is 
expensive. In addition, it can result in false-positives 
with variations of sensitivity and specificity. Nested 
PCR targeting the ssrRNA genes is the most sensitive 
and specific method, but it is also expensive, requiring 
an amplification infrastructure, equipment and reagents. 
Besides, it is a relatively sophisticated and time-consuming 
procedure, which may not be applicable to malaria 
diagnosis in remote areas. On the other hand, the detection 
limit of nested-PCR and nRT-PCR are as low as 5-10 and 
22 parasites/μL of blood, respectively45,46. Therefore, it is 
an important technique to investigate low parasite density 
in asymptomatic malaria patients. 
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